Gap junctions are present in the juxtaglomerular apparatus enabling intercellular communication. Our study determined the location of different connexin subtypes within the juxtaglomerular apparatus of the rat, and the role of these subtypes in renal hemodynamics through the use of specific mimetic peptides. Immunohistochemical analysis showed connexins 37 and 40 expression in the endothelial and renin-secreting cells of the afferent arteriole, while connexin 40 was also found in extra-and intraglomerular mesangial cells. In contrast, connexin 43 was weakly expressed in endothelial cells of the afferent arteriole and within the glomerulus. Intra-renal infusion of the peptides (GAP) reported to block specific gap junctions ( Cx37,43 GAP27 or Cx40 GAP27), elevated blood pressure, plasma renin activity, and angiotensin II levels, while decreasing renal plasma flow without a significant change in the glomerular filtration rate. Subsequent restoration of blood pressure reduced both renal plasma flow and glomerular filtration rate. In contrast, Cx43 GAP26 reduced glomerular filtration rate without alterations in blood pressure, renal plasma flow, plasma renin activity, or angiotensin II levels. Hence, connexins 37 and 40 are expressed in the rat juxtaglomerular apparatus and these proteins control, in part, the renin-angiotensin system and renal autoregulation.
Gap junctions enable direct intercellular communication via low molecular weight chemical mediators (o1kDa) or changes in membrane potential. 1 Six connexins (Cx) oligomerize to form a connexon or hemichannel in the plasma membrane. At least 20 Cxs have been cloned and each connexon may be composed of a single type of Cx (homomeric) or of different Cxs (heteromeric). Docking with a counterpart from an adjacent cell creates a gap junction, which can be made of identical (homotypic) or different connexons (heterotypic). The loss of a particular Cx subtype by genetic mutation could therefore not only change ionic communication, but also alter the range of molecules exchanged between two cells if the other Cxs are expressed by the same cells. 2 Moreover, data using animals in which a specific Cx has been deleted suggest that compensatory changes can occur in the remaining Cxs. 3 Nevertheless, there is an emerging concept that Cxs play an important role in physiological processes including ovarian follicle formation, spermatogenesis, lens transparency, cardiac development, and blood pressure regulation. [1] [2] [3] [4] [5] [6] Various Cxs are expressed in the cardiovascular system. In the heart, Cxs40 and 43 have been shown to play important roles in cardiac development and impulse propagation, [5] [6] [7] while in blood vessels, gap junctions within the endothelium, smooth muscle, and between the two cell layers have been implicated in a number of vasomotor responses that may regulate vascular tone and blood pressure. 3, 8 The juxtaglomerular apparatus is anatomically characterized by the interposition of mesangial cells between macula densa cells and afferent arteriolar myocytes. 9, 10 Although there is a wide interstitial space between the macula densa and the mesangial cells, 11 afferent arteriolar myocytes and endothelial cells are tightly connected with gap junctions, which enable intercellular communication. 9, 12 In the kidneys of rats and mice, Cx40 is highly expressed in the endothelial and renin-secreting cells of the afferent arterioles and in the extra-and intraglomerular mesangial cells. 7, [13] [14] [15] Cx37 is also highly expressed in the juxtaglomerular apparatus of mice, as well as in the smooth muscle cells of renal arteries and arterioles, 14 while Cx43 is only detected in endothelial cells. 14 Importantly, deletion of Cx40 in mice has been reported to result in hypertension 16, 17 and recently these modified mice have been shown to lack the inhibition of renin secretion by high intravascular pressure. 18 However, replacement of Cx43 with Cx32 has been reported to reduce renin expression and prevent the development of renovascular hypertension. 19 In contrast, in rats, expression of Cx37 has been described to be limited to endothelial cells, 15 while expression of Cx43 remains controversial. 7, 15, 20, 21 These data suggest that the renal expression of particular Cx subtypes may vary between rats and mice.
Gap junctions within the juxtaglomerular apparatus may play an important role in the autoregulation of renal blood flow, which in turn is mediated by both myogenic response of preglomerular vessels and tubuloglomerular feedback, which links constriction of terminal portion of the afferent arteriole to alterations in salt concentration at the macula densa. Gap junctions in the juxtaglomerular apparatus may also play a role in regulation of renin-angiotensin system. In this study we tested this hypothesis by determining the expression of Cxs37, 40, and 43 in the juxtaglomerular apparatus, and by investigating the specific roles of these Cxs in renal hemodynamics and renin-angiotensin system using subtypeselective gap junction blockers in rats. As many of the putative gap junction antagonists have been reported to have nonspecific effects, 22, 23 we used the GAP peptides to probe physiological function. These peptides are reported to block specific Cxs through mimicry of extracellular sequences. 24, 25 
RESULTS Immunohistochemistry
Strong staining for Cx37 was found demarking endothelial cell borders in all arteries ( Figure 1a ); however, no evidence was found for any staining in the smooth muscle cells. Staining was also found among endothelial cells of the afferent arterioles and this continued up to the point where the arterioles entered the glomerulus (Figure 1b , c and inset, e). Renin-secreting cells colocalized with the terminal myosinstained cells of the afferent arteriole at the entrance to the glomerulus (Figure 4d ). Punctate staining for Cx37 could be found clearly associated with these cells (Figures 1e, f, and 4e). Occasionally, weak punctuate staining could be found between smooth muscle cells at more proximal sites along the afferent arteriole.
In the glomerulus, staining for Cx37 was confined to the vascular pole around the entry of the afferent arteriole and exit of the efferent arteriole (Figure 1b and e). There was no evidence for any Cx37 expression in extra-glomerular mesangial cells. Punctate staining for Cx37 could be seen weakly in the endothelial layer of the exiting efferent arterioles (Figure 1b, d and inset). Although this staining increased in intensity with distance from the glomerulus, it was always less extensive than that in the afferent arterioles ( Figure 1b Cx40 was strongly expressed in the endothelium of all arteries (Figure 2a ) and this staining continued along the endothelial cells of the afferent arterioles and into the glomerulus (Figure 2b ). Renin-secreting cells expressed Cx40 strongly (Figures 2b, c and inset,); however, there was no evidence for expression of Cx40 in smooth muscle cells along the afferent arteriole, or in the efferent arteriole, or any other artery.
Cx40 was expressed throughout the glomerulus and extremely strongly in the extra-glomerular mesangium ( Figure  2b-d ). Cx40 expression within the glomerulus did not colocalize with the endothelial marker, von Willebrand factor. There was no expression of Cx40 in either the endothelium or smooth muscle of the efferent arterioles (Figure 2d and inset).
While Cx43 was expressed strongly in the endothelium of large and small arteries ( Figure 3a In contrast, Cx43 was not expressed in the endothelium of the efferent arterioles ( Figure 3b , d and inset) and there was no expression in the smooth muscle of any vessel. Cx43 was also not expressed in the renin-secreting cells or extra-glomerular mesangium (Figure 3c and d). Within the glomerulus, there was sparse punctate staining, which was abolished by preincubation in the antigenic peptide (compare Figures 3b and 4c ). This Cx43 staining did not colocalize with Cx40 or with the endothelial marker, von Willebrand factor. All staining attributed to the antibodies against Cxs37, 40, and 43 was abolished by preincubation with the antigenic peptide or omission of the primary antibody ( Figure 4a -c, Cxs37, 40, and 43, respectively).
Hemodynamics
Intra-renal infusion of Cx40 GAP27 and Cx37,43 GAP27 resulted in an elevation of blood pressure (Figure 5a ; Cx40 GAP27 100±1 to 110±2 mm Hg, Po0.05; Cx37,43 GAP27 98±2 to 114 ± 2 mm Hg, Po0.01), while infusion of Cx43 GAP26 did not alter blood pressure (Figure 5a ). Furthermore, the magnitude of the increase in blood pressure by Cx37,43 GAP27 was greater than that by Cx40 GAP27 (Po0.05). Renal plasma flow (RPF) was decreased by Cx40 GAP27 (4.25 ± 0.22 to 3.70±0.24 ml per min per g kidney wt, Po0.05) and by Cx37, 43 GAP27 (4.48±0.33 to 3.80±0.26ml per min per g kidney wt, Po0.01). Although Cx43 GAP26 tended to reduce RPF, it did not attain significance ( Figure 5b ). Glomerular filtration rate (GFR) was not altered by either Cx40 GAP27 or Cx37, 43 GAP27 ( Figure 5c ), but was decreased by Cx43 GAP26 (1.02 ± 0.03 to 0.92 ± 0.03 ml per min per g kidney wt, Po0.05). Filtration fraction was raised by infusion of either Cx40 GAP27 (25±2 to 28±2%, Po0.05) or Cx37,43 GAP27 (23±2 to 28±2%, Po0.05), but not by Cx43 GAP26 (Figure 5d ).
In rats treated with Cx37,43 GAP27, pressure restoration caused a further reduction in RPF (to 3.39 ± 0.22 ml per min per g kidney wt, Po0.05) and also reduced GFR (1.05 ± 0.04 to 0.97 ± 0.03 ml per min per g kidney wt, Po0.05). Returning mean arterial pressure to the basal level in the presence of Cx40 GAP27 also lowered GFR (1.03±0.02 to 0.95±0.02 ml per min per g kidney wt, Po0.05) and RPF (to 3.47±0.22 ml per min per g kidney wt, Po0.05).
Intravenous infusion of angiotensin II (10 ng min À1 ) elevated blood pressure (102 ± 4 to 120 ± 3 mm Hg, Po0.01) and reduced RPF (4.45 ± 0.52 to 3.50 ± 0.50 ml per min per g kidney wt, Po0.05) without any change in GFR (1.02 ± 0.03 to 1.00 ± 0.03 ml per min per g kidney wt), effects similar to those seen for Cx37,43 GAP27 and Cx40 GAP27. The dose of angiotensin II was selected to obtain an increase in blood pressure comparable to GAP peptides. However, pressure restoration to 101 ± 3 mm Hg induced no further change in either RPF (to 3.52 ± 0.51 ml per min per g kidney wt) or GFR (to 0.99 ± 0.02 ml per min per g kidney wt) during angiotensin II infusion.
Renin-angiotensin Figure 6a depicts the effects of GAP peptide on plasma renin activity. Plasma renin activity was elevated by an intra-renal infusion of either Cx40 GAP27 (20±2 ng ml À1 h À1 , n ¼ 6, Po0.05) or Cx37,43 GAP27 (24±1 ng ml À1 h À1 , n ¼ 6, Po0.01), compared to the control (10±1 ng ml À1 h À1 ). The magnitude of increments in plasma renin activity tended to be higher in rats treated with Cx37,43 GAP27 than Cx40 GAP27 but it did not attain statistical significance. However, the infusion of Cx43 GAP26 had no effect on plasma renin activity. Similarly, angiotensin II levels were elevated by an intra-renal infusion of either Cx40 GAP27 (47 ± 2 pg ml À1 , n ¼ 6, Po0.05) or Cx37, 43 GAP27 (72 ± 10 pg ml À1 , n ¼ 6, Po0.01), compared to the control (24 ± 3 pg ml À1 , n ¼ 6; Figure 6b ). The degree of increase in angiotensin II was significantly greater in rats treated with Cx37,43 GAP27 than Cx40 GAP27 (Po0.05). In contrast, infusion of Cx43 GAP26 had no effect on angiotensin II levels.
DISCUSSION
Our anatomical studies have demonstrated expression of both Cx37 and Cx40 in the endothelial cells of the afferent arteriole and the renin-secreting cells of the juxtaglomerular apparatus, with additional expression of Cx40 in the extraand intraglomerular mesangial cells. In contrast, Cx43 was only detected weakly in the endothelium of the afferent arteriole, sparsely within the glomerulus, and not at all in the juxtaglomerular apparatus. Importantly, our functional studies using specific Cx mimetics have shown that inhibition of the action of Cxs37 and 40, but not Cx43, in the intact kidney leads to an increase in plasma renin activity and angiotensin II levels, a significant increase in blood pressure, and decrease in RPF. Restoration of blood pressure to control levels produced further decreases in RPF and GFR, changes which were not seen following pressure restoration during infusion of angiotensin II. These data suggest that gap junctions containing Cxs37 and 40 are integral to the control of the renin-angiotensin system and to renal autoregulation.
Cx40 was widely distributed in the rat juxtaglomerular apparatus, including the extra-and intraglomerular mesangium, preglomerular endothelial cells, and renin-secreting cells, consistent with previous studies in mice and rats. [13] [14] [15] Our physiological data demonstrating a decrease in RPF and increase in blood pressure following infusion of Cx40 GAP27 concur with those of de Vriese et al., 26 who showed a similar effect with a bolus intrarenal infusion of Cx40 GAP27. In addition, we found that Cx40 GAP27 increased filtration fraction without any change in GFR, suggesting preferential postglomerular vasoconstriction. Although de Vriese et al. 26 found an inhibitory effect of Cx40 GAP27 on endotheliumderived hyperpolarizing factor in the rat kidney, it is unlikely that effects on endothelium-derived hyperpolarizing factor were involved in these changes since Wang and Loutzenhiser 27 showed that endothelium-derived hyperpolarizing factor dilated afferent but not efferent arterioles, and hence loss of endothelium-derived hyperpolarizing factor would be expected to lead to preglomerular vasoconstriction. However, we have shown for the first time that intra-renal infusion of Cx40 GAP27 elevated angiotensin II and inhibited renal autoregulation following pressure restoration. Although angiotensin II constricts both afferent and efferent arterioles, 28 autoregulatory adjustment of vascular tone is limited to preglomerular vessels, including the afferent arteriole. [29] [30] [31] An elevation of angiotensin II coupled with attenuation of autoregulatory tone by Cx40 GAP27 would produce preferential postglomerular constriction. Inhibition of Cx40 increased blood pressure in this study. Mice deficient in Cx40 showed impaired conduction of arteriolar vasodilation in skeletal muscle, irregular arteriolar vasomotion, hypertension, and a high incidence of cardiac malformation. 6, 16, 17, 32 The possibility therefore exists that Cx40 GAP27 spilling over from the kidney might have inhibited systemic vascular Cx40 and increased blood pressure. Effects of spillover might also be mediated through the heart as Cx40 is expressed in the cardiac conducting system. 7 However, we observed regular pulses throughout the experimental periods, speaking against this possibility. An angiotensin receptor blocker reduced blood pressure in both wild-type and Cx40 knockout mice. 16 We have not used angiotensin receptor blockers in this study; however, it seems likely that activation of the renin-angiotensin system is responsible for the elevation in blood pressure in this study.
Although Cx43 has been suggested to be involved in blood pressure regulation in rats and mice, 19, 26 our data suggest that in rats, additional effects on blood pressure are due to Cx37 but not Cx43. We have shown for the first time that Cx37 is expressed in renin-secreting cells and in the afferent and efferent arteriolar endothelial cells, while Cx43 is only weakly expressed in the endothelial cells of the afferent arterioles. In functional studies, Cx37,43 GAP27 increased angiotensin II levels and decreased RPF without changes in GFR, suggesting a preferential postglomerular vasoconstriction. Like Cx40 GAP27, Cx37,43 GAP27 impaired renal autoregulation. In contrast to Cx37,43 GAP27, Cx43 GAP26 had no effect on either the renin-angiotensin system or renal autoregulation, leading us to conclude that the results were due to the involvement of Cx37 and not Cx43. Surprisingly, mice deficient in Cx37 showed impaired conduction of arteriolar vasodilation 33 and susceptibility to atherogenesis, 34 but were normotensive. 3 Since Cx37,43 GAP27 produced an increase in blood pressure in the this study and an increase in angiotensin II, compensatory changes in other Cxs in the Cx37 knockout mice, as has been described previously, cannot be ruled out. 3 In this study, Cx43 was localized to preglomerular endothelial cells in the rat renal vasculature similar to previous data in rats and mice. 7, 14 However, in contrast to Barajas et al. 20 and Guo et al., 21 we did not find Cx43 expression in extraglomerular mesangial cells, although Cx43 was sparsely expressed within the glomerulus. Since this latter Cx43 expression did not colocalize with Cx40, it is likely to be confined to podocytes. Intra-renal infusion of Cx43 GAP26 decreased GFR without changes in filtration fraction, consistent with an effect of Cx43 GAP26 in eliciting preglomerular vasoconstriction. Although Cx43 GAP26 tended to decrease RPF, it did not reach statistical significance, suggesting a limitation of the measurements. Mice in which Cx43 is deleted die at birth and data on blood pressure in endothelium-specific Cx43 knockout mice are controversial; mice being either hypotensive 35 or normotensive. 36 Mice in which Cx43 has been replaced with Cx32 showed decreased expression and secretion of renin, but were normotensive. 19 In this study, Cx43 GAP26 neither altered blood pressure nor the renin-angiotensin system. Taken together, it seems unlikely that acute inhibition of intra-renal Cx43 alters release of vasoconstrictors or vasodilators. Alternatively, it remains possible that Cx43 GAP26 might alter the ultrafiltration coefficient due to the blockade of Cx43 on podocytes. Renin release is controlled by various mechanisms, including afferent arteriolar pressure, macula densa, calcium, and sympathetic nerve activity. Paracrine factors such as angiotensin II, nitric oxide, and prostaglandins are also involved. 37, 38 Our data support the notion that Cxs regulate the renin-angiotensin system and suggest that the blunted cell communication due to the GAP peptides contributes to the activation of renin-angiotensin system. An interruption to conduction of autoregulatory signals, especially tubuloglomerular feedback, could stimulate renin release directly by decreasing cytosolic calcium in renin-secreting cells, or indirectly by decreasing afferent arteriolar pressure. 31 If one assumes that TGF is confined to the distal afferent arteriole and the myogenic response to more upstream segments, then, if autoregulation should become impaired due to failure of TGF alone but not the myogenic response, then this could be associated with a drop in local intravascular pressure in this segment ( Figure S1 ). The present data indicate that both Cx37 and Cx40 are expressed in afferent arteriolar endothelial cells. Expression of Cx40 is upregulated in endothelial cells and renin-secreting cells in kidneys of rats with renovascular hypertension. 7 Inhibition of intercellular communication between renin-secreting cells and endothelial cells by GAP peptides may result in an elevation of renin and angiotensin II, possibly modifying the actions of nitric oxide and prostanoids. While recent data may suggest that Cx37,43 GAP27 and Cx40 GAP27 could manifest non-junctional effects, it is possible that some of these effects of the GAP peptides could be via Cx hemichannels. 8, 39 Bao et al. 40 demonstrated that Cx hemichannels are mechanosensitive and Yao et al. 41 reported that mechanical stimuli enhanced ATP release from cultured juxtaglomerular cells, presumably suppressing renin secretion. Clearly, further experiments are required to assess how Cxs control renin release precisely. Experiments in which arterial pressure is controlled independently of the deletion of specific Cxs would be important.
In summary, our findings provide evidence that intercellular communication through Cx37 and Cx40 in the juxtaglomerular apparatus transduces signals mediating renal autoregulation and participates in regulation of the reninangiotensin system.
MATERIALS AND METHODS
The anatomical and physiological studies described here were conducted independently and in a blinded fashion in two separate locations, Australia and Japan, respectively.
Immunohistochemistry
Male Wistar Kyoto rats aged 8-10 weeks were anesthetized with ether and decapitated under a protocol approved by the Animal Experimentation and Ethics Committee of the Australian National University. Both kidneys were removed and 1-2 mm thick transverse sections cut and immersion fixed in cold acetone for 20 min at 41C. Blocks were infiltrated with 30% sucrose in phosphate-buffered saline, embedded in Cryo-M-Bed (Bright Instrument Company, Cambridge, UK) and cryosectioned coronally at 30 mm. Sections were preincubated in 2% bovine serum albumin, 0.2% Triton X-100 in phosphate-buffered saline for 30 min, and incubated for 1 or 2 days at room temperature in the same solution containing sheep antibodies against Cxs37 and 40, 42,43 rabbit antibodies against Cx43 (1:250; Zymed, San Francisco, CA, USA), or mouse or sheep antibodies against rat renin (1:500, Swant, Bellinzona, Switzerland; 1:1000, Sapphire Bioscience, Redfern, NSW, Australia respectively). Staining was detected using Cy3-conjugated anti-goat (1:600) or anti-rabbit (1:100) immunoglobulins (Jackson Labs, West Grove, Pennsylvania, USA) or Alexa Fluor 568 anti-mouse immunoglobulins (1:800; Molecular Probes, Eugene, Oregon, USA) in phosphate-buffered saline containing 0.01% Triton X-100. Localization of the staining in the arteries and arterioles was confirmed by subsequent staining with rabbit anti-smooth muscle myosin (1:250; Goschel Stewart, Darmstadt, Germany) or rabbit antihuman von Willebrand factor (1:300; Dako, Glostrup, Denmark) for 1 h at room temperature and detected using fluorescein isothiocyanateconjugated anti-rabbit immunoglobulin (1:40; Dako) .
Subtype specificity of all three Cx antibodies has been previously demonstrated using immunohistochemistry and western blotting of COS cells transfected with plasmid DNA encoding Cxs37, 40, or 43. 43 Further tests of specificity involved omission of the primary antibody or preincubation of the primary antibody with a 10-fold excess of the immunizing peptide.
Sections were mounted in buffered glycerol and viewed with a Leica TCS confocal scanning microscope. Series of images of the juxtaglomerular apparatus were collected every 1 mm and reconstructed to provide views throughout the vessel and glomerular depth. Sections of kidneys taken from each of four different rats were tested with antibodies against all three of the Cxs.
Hemodynamics
Experiments were performed using 8-to 10-week-old male Wistar Kyoto rats (Shizuoka Laboratory Animal Center, Shizuoka, Japan) and all experimental protocols were approved by the Ethical Committee of the Saitama Medical College. Animals were allowed free access to tap water and standard rat chow (CE-2, Nihon CLEA, Tokyo, Japan). On the day of experiment, the rats were anesthetized with pentobarbital sodium (50 mg kg À1 , intraperitoneally) and placed on a thermostatically controlled heated table to keep body temperature at 371C as detailed previously. 10, 44 A tracheostomy was performed, and the right jugular vein was cannulated with polyethylene tubing (PE50) to allow infusion of solutions and additional anesthetic. The animals were infused at the rate of 1.2 ml h À1 with isotonic saline solution containing 6% bovine serum albumin (Sigma-Aldrich Chemicals, St Louis, MO, USA) during surgery, and thereafter with isotonic saline solution containing 1% bovine serum albumin, 7.5% Inutest (Laevosan-Gesellschaft, Linz/ Donau, Austria), and 1.5% para-aminohippuric acid (Merck Sharp and Dohme, West Point, PA, USA) to enable calculation of GFR and effective RPF. The left femoral artery was catheterized with PE50 filled with heparinized saline (100 U ml À1 ) to allow blood sampling and continuous arterial pressure measurements with a transducer (DX-100, Nihon Kohden Co. Ltd, Tokyo, Japan) and a polygraph recorder (RM-7000, Nihon Kohden). Mean arterial pressure was used as renal arterial pressure. There was no irregularity of the arterial pulse throughout experimental periods. The abdomen was opened by a midline incision. The left ureter was cannulated (PE10), and urine was collected under mineral oil in preweighed tubes.
An adjustable clamp was placed on the aorta above the left renal artery to control left renal arterial pressure. For GAP peptide experiments, the left adrenal artery was cannulated with extended PE10 to infuse heparinized saline or GAP peptides (5 mg intraarterially followed by 0.2 mg min À1 ) at a rate of 0.6 ml h À1 , 10, 26, 45 and the solution for transjugular infusion was adjusted to that containing 2% bovine serum albumin and infused at the rate of 0.6 ml h À1 to make water load similar. In the case of Cx40 GAP27 saline containing acetic acid was used as a vehicle. Preliminary studies showed that hemodynamic effects caused by the GAP peptides were maintained constant for 4 h at the doses used in this study. Rats were allowed to breathe air enriched with 100% oxygen, which markedly improves the stability of arterial blood pressure. After completion of surgery, 1 h of equilibration was allowed before initiating experimental protocols.
The experiments contained three groups, and were performed on six rats for each group to characterize systemic and renal hemodynamic effects of GAP peptides. Initially, saline was infused into the left renal artery through the adrenal artery. Two consecutive 20-min control clearances were carried out. Then, the infusion of GAP peptide into the adrenal artery was initiated, and continued until the end of study. Cx43 GAP26 (Severn Biotech, Worcestershire, UK), Cx40 GAP27 (Severn Biotech), and Cx37,43 GAP27 (Sigma-Aldrich) were used for each group. 26, 46 A 20-min equilibration period was allowed before initiating two consecutive 20-min clearance periods. Then, the aortic clamp was tightened to return renal arterial pressure to the control level if necessary. Another 20-min equilibration period was allowed before initiating two consecutive 20-min clearance periods. In preliminary studies, the intra-aortic injection of Cx40 GAP27, Cx43 GAP26, and Cx37,43 GAP27 (1 mg) induced a prompt increase, a decrease, and an insignificant change in blood pressure, respectively. Intra-renal infusion of Cx40 GAP27 and Cx37,43 GAP27 resulted in an elevation of blood pressure. That of Cx43 GAP26 did not alter blood pressure. These discrepancies suggest that the amount of GAP peptide spilled over from the kidney was not large enough to affect the systemic circulation. In a fourth group of rats (n ¼ 5), the effects of intravenous infusion of angiotensin II (10 ng min À1 ) on renal hemodynamics were assessed in a similar manner, and served as the time control. This dose of angiotensin II infusion would induce about three-fold increases in plasma angiotensin II. 47 Previous study indicated that renal angiotensin II levels were much higher than plasma levels in rats. 44 Arterial blood samples (approximately 0.2 ml) were taken at the midpoint of each clearance period. Cells were separated by centrifugation and plasma was removed. Urine volume was determined gravimetrically. Inulin and para-aminohippuric acid concentrations in both plasma and urine were measured by standard spectrophotometry. At the end of the experiment, the rats were killed with an overdose of pentobarbital, and the left kidney was removed, decapsulated, blotted dry, and weighed.
Renin-angiotensin
In additional experiments, angiotensin II levels were determined in four groups of rats using RIA, as described previously. 10, 44 Surgical procedures were the same as the above, except that the ureter was not cannulated. After 1 h of equilibration, the three GAP peptides were infused separately into the adrenal artery in three groups of rats. The remaining group served as the control in which saline was infused into the adrenal artery. Twenty minutes later, 2 ml of blood sample was taken from the femoral artery in chilled tubes containing EDTA. In a similar manner, plasma renin activity was measured separately in four groups of rats with RIA (Renin RIA Kit, Yamasa Soysauce Co. Ltd, Chiba, Japan). Blood samples were centrifuged at 41C for 10 min. Plasma was kept frozen until assayed. We confirmed that each of three types of GAP peptides did not interact against the assay.
Statistics
Data were expressed as means±s.e.m. Statistical analysis was performed, using analysis of variance for repeated measurements and Student's t-test with or without Bonferroni correction for multiple comparisons when appropriate. Po0.05 was considered as statistically significant.
